# A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

> **NCT04414397** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 205 (actual)

## Conditions studied

- Temple Hollowing

## Interventions

- **DEVICE:** JUVÉDERM® VOLUMA® XC
- **OTHER:** No-treatment control

## Key facts

- **NCT ID:** NCT04414397
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-28
- **Primary completion:** 2022-10-17
- **Final completion:** 2022-10-17
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414397, "A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04414397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*